[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @HemostemixInc Thomas Smeenk Thomas Smeenk posts on X about $hem, $hmtxf, $2vf0, files the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::22017380/interactions)  - X Week XXX -XX% - X Month XXX -XXXX% - X Months XXXXX +1,343% ### Mentions: X [#](/creator/twitter::22017380/posts_active)  - X Week X +400% - X Month XX no change - X Months XX +1,000% ### Followers: XXX [#](/creator/twitter::22017380/followers)  - X Week XXX +1.10% - X Month XXX +3.50% - X Months XXX +4.10% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::22017380/influencer_rank)  ### Social Influence [#](/creator/twitter::22017380/influence) --- **Social topic influence** [$hem](/topic/$hem) #2, [$hmtxf](/topic/$hmtxf) #1, [$2vf0](/topic/$2vf0) #1, [files](/topic/files), [protocol](/topic/protocol), [pad](/topic/pad), [targets](/topic/targets) ### Top Social Posts [#](/creator/twitter::22017380/posts) --- Top posts by engagements in the last XX hours "What if memory loss starts in your blood vessels 🧠In vascular dementia reduced blood flow may damage brain tissue linking heart & brain health more closely than ever. Learn how Hemostemix is advancing patient-led stem cell research: 🔗 $HEM $HMTXF $2VF0 #VascularDementia #StemCellResearch #Biotech" [X Link](https://x.com/HemostemixInc/status/1978509409065070637) [@HemostemixInc](/creator/x/HemostemixInc) 2025-10-15T17:12Z XXX followers, XXX engagements "🚨 New Milestone: $HEM $HMTXF $2VF0 Hemostemix adds Refractory Angina to its Phase X basket trial of ACP-01. Targeting patients with daily chest pain & no remaining treatment options. Read more: 🔗 #Biotech #Cardiology #ClinicalTrials" [X Link](https://x.com/HemostemixInc/status/1978800263843479804) [@HemostemixInc](/creator/x/HemostemixInc) 2025-10-16T12:28Z XXX followers, XXX engagements "🚨 Milestone: Hemostemix $HEM 📷 $HMTXF $2VF0 files FDA Pre-IND 1517 for ACP-01 (VesCell) basket protocol. One trial. Multiple billion-$ markets: PAD CLI angina CHF vascular dementia. 📖 Read more: #FDA #StemCells" [X Link](https://x.com/HemostemixInc/status/1970820513929810407) [@HemostemixInc](/creator/x/HemostemixInc) 2025-09-24T12:00Z XXX followers, XXX engagements "5% of adults over XX live with daily chest pain and no cure. Hemostemixs new Phase X trial targets refractory angina using ACP-01 a patients own cells to help restore blood flow & repair heart tissue. Learn more: #Hemostemix $HEM $HMTXF $2VF0" [X Link](https://x.com/HemostemixInc/status/1979155441029648806) [@HemostemixInc](/creator/x/HemostemixInc) 2025-10-17T12:00Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Thomas Smeenk posts on X about $hem, $hmtxf, $2vf0, files the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social topic influence $hem #2, $hmtxf #1, $2vf0 #1, files, protocol, pad, targets
Top posts by engagements in the last XX hours
"What if memory loss starts in your blood vessels 🧠In vascular dementia reduced blood flow may damage brain tissue linking heart & brain health more closely than ever. Learn how Hemostemix is advancing patient-led stem cell research: 🔗 $HEM $HMTXF $2VF0 #VascularDementia #StemCellResearch #Biotech"
X Link @HemostemixInc 2025-10-15T17:12Z XXX followers, XXX engagements
"🚨 New Milestone: $HEM $HMTXF $2VF0 Hemostemix adds Refractory Angina to its Phase X basket trial of ACP-01. Targeting patients with daily chest pain & no remaining treatment options. Read more: 🔗 #Biotech #Cardiology #ClinicalTrials"
X Link @HemostemixInc 2025-10-16T12:28Z XXX followers, XXX engagements
"🚨 Milestone: Hemostemix $HEM 📷 $HMTXF $2VF0 files FDA Pre-IND 1517 for ACP-01 (VesCell) basket protocol. One trial. Multiple billion-$ markets: PAD CLI angina CHF vascular dementia. 📖 Read more: #FDA #StemCells"
X Link @HemostemixInc 2025-09-24T12:00Z XXX followers, XXX engagements
"5% of adults over XX live with daily chest pain and no cure. Hemostemixs new Phase X trial targets refractory angina using ACP-01 a patients own cells to help restore blood flow & repair heart tissue. Learn more: #Hemostemix $HEM $HMTXF $2VF0"
X Link @HemostemixInc 2025-10-17T12:00Z XXX followers, XX engagements
/creator/twitter::HemostemixInc